Q3 2025 Management View James Davis, Chairman, CEO & President, stated that "Our third quarter performance underscores strong ...

Quest Diagnostics has been experiencing robust volume growth in its core business (excluding COVID testing), banking on the growth of new physician and hospital customers, a more favorable test mix ...

Quest Diagnostics DGX is gaining from strong existing customer relationships, new customer wins, broad health plan access and advanced diagnostics offerings. The stock carries a Zacks Rank #2 (Buy) ...

Quest Diagnostics DGX has been gaining from its existing solid customer relationships, new customer wins, broad health plan access and advanced diagnostics offerings. The stock carries a Zacks Rank #2 ...

Quest Diagnostics Inc (NYSE:DGX) posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26. Sales increased 8.5% year-over-year to $2.49 billion, beating the consensus ...

SUNNYVALE, Calif. and SECAUCUS, N.J., March 18, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a collaboration with Google Cloud to ...

MADISON, N.J., May 6, 2011 /PRNewswire/ -- Quest Diagnostics® (NYSE: DGX) today announced that Care360 user Paulo Andre, M.D., a neurologist in Framingham, MA, was the first Care360 EHR customer to ...